Bioerodible magnesium alloy microstructures for endoprostheses
US-9522220-B2 · Dec 20, 2016 · US
US10358703B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10358703-B2 |
| Application number | US-201515525471-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 8, 2015 |
| Priority date | Nov 13, 2014 |
| Publication date | Jul 23, 2019 |
| Grant date | Jul 23, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure provides a magnesium alloy and a preparation method and an application thereof. Based on the total weight of the magnesium alloy, the magnesium alloy includes 2-3.5 wt % of Ce, 0.01-0.2 wt % of R, 0.8-1.5 wt % of Mn, 0-0.01 wt % of Fe, 0-0.01 wt % of Cu, 0-0.01 wt % of Ni, 0-0.01 wt % of Co, 0-0.01 wt % of Sn, 0-0.01 wt % of Ca, and 94.74-97.19 wt % of Mg, wherein R is at least one selected from Al and Zn.
Opening claim text (preview).
What is claimed is: 1. A magnesium alloy, based on the total weight of the magnesium alloy, the magnesium alloy comprises: 2-3.5 wt % of Ce, 0.01-0.2 wt % of R, 0.8-1.5 wt % of Mn, 0-0.01 wt % of Fe, 0-0.01 wt % of Cu, 0-0.01 wt % of Ni, 0-0.01 wt % of Co, 0-0.01 wt % of Sn, 0-0.01 wt % of Ca, 94.74-97.19 wt % of Mg, wherein R is selected from the group consisting of Al, Zn, and combinations thereof; and wherein the magnesium alloy includes, based on the total weight of the magnesium alloy, not more than 0.2 wt % of the combined weight of one or more metals selected from the group consisting of Y, Sc, La, Pr, Nd, Pm, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, Lu, Be, Zr, Li, Na, K, Sr, Ba, Ga, In, Ge, Sb, Bi, V, Nb, Cr, Mo, W, Re, Tc, Ru, Pd, Pt, Ag and Au. 2. The magnesium alloy according to claim 1 , wherein the content of Ce in the magnesium alloy is 2.2-3 wt %. 3. The magnesium alloy according to claim 1 , wherein the content of R in the magnesium alloy is 0.1-0.2 wt %. 4. The magnesium alloy according to claim 1 , wherein the content of Mn in the magnesium alloy is 0.9-1.4 wt %. 5. The magnesium alloy according to claim 1 , wherein the alloy is formed into a heat conductive structure member. 6. A magnesium alloy, based on the total weight of the magnesium alloy, the magnesium alloy consists of: 2-3.5 wt % of Ce, 0.01-0.2 wt % of R, 0.8-1.5 wt % of Mn, 0-0.01 wt % of Fe, 0-0.01 wt % of Cu, 0-0.01 wt % of Ni, 0-0.01 wt % of Co, 0-0.01 wt % of Sn, 0-0.01 wt % of Ca, and a balance of Mg, wherein R is selected from the group consisting of Al, Zn, and combinations thereof. 7. The magnesium alloy according to claim 6 , wherein the content of Ce in the magnesium alloy is 2.2-3 wt %. 8. The magnesium alloy according to claim 6 , wherein the content of R in the magnesium alloy is 0.1-0.2 wt %. 9. The magnesium alloy according to claim 6 , wherein the content of Mn in the magnesium alloy is 0.9-1.4 wt %. 10. The magnesium alloy according to claim 6 , wherein the alloy is formed into a heat conductive structure member. 11. A method of preparing a magnesium alloy, comprising: melting the raw material of the magnesium alloy in a predetermined proportion, so as to obtain alloy melt; carrying out molding treatment to the alloy melt, so as to obtain the magnesium alloy; wherein the magnesium alloy is the magnesium alloy according to claim 1 . 12. The method according to claim 11 further comprising carrying out aging treatment to the obtained magnesium alloy. 13. The method according to claim 12 , wherein the aging treatment is carried out at a temperature of 120° C.-350° C. 14. The method according to claim 11 , wherein the duration of the aging treatment is at least 0.5 hours.
Related publications grouped by family.
Answers are generated from the same data shown on this page.